InMode (NASDAQ:INMD) versus SNDL (NASDAQ:SNDL) Financial Survey

SNDL (NASDAQ:SNDLGet Free Report) and InMode (NASDAQ:INMDGet Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, risk, dividends and earnings.

Risk and Volatility

SNDL has a beta of 0.92, indicating that its share price is 8% less volatile than the S&P 500. Comparatively, InMode has a beta of 1.91, indicating that its share price is 91% more volatile than the S&P 500.

Institutional & Insider Ownership

68.0% of InMode shares are owned by institutional investors. 6.9% of InMode shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Earnings and Valuation

This table compares SNDL and InMode”s gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
SNDL $677.32 million 0.49 -$11.29 million ($0.03) -42.67
InMode $370.49 million 2.38 $93.83 million $1.36 11.29

InMode has lower revenue, but higher earnings than SNDL. SNDL is trading at a lower price-to-earnings ratio than InMode, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares SNDL and InMode’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
SNDL -1.19% -1.02% -0.85%
InMode 23.27% 13.47% 11.95%

Analyst Ratings

This is a summary of current recommendations for SNDL and InMode, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SNDL 1 1 1 0 2.00
InMode 1 6 1 0 2.00

SNDL currently has a consensus target price of $5.00, suggesting a potential upside of 290.62%. InMode has a consensus target price of $16.00, suggesting a potential upside of 4.17%. Given SNDL’s higher possible upside, research analysts plainly believe SNDL is more favorable than InMode.

Summary

InMode beats SNDL on 10 of the 12 factors compared between the two stocks.

About SNDL

(Get Free Report)

SNDL Inc. engages in the production, distribution, and sale of cannabis products in Canada. The company operates through Liquor Retail, Cannabis Retail, Cannabis Operations, and Investments segments. It engages in the cultivation, distribution, and sale of cannabis for the adult-use and medical markets; sells wines, beers, and spirits through wholly owned liquor stores; and private sale of recreational cannabis through wholly owned and franchised retail cannabis stores. In addition, the company produces and distributes inhalable products, such as flower, pre-rolls, and vapes. It offers its products under the Top Leaf, Sundial Cannabis, Palmetto, and Grasslands brands. The company was formerly known as Sundial Growers Inc. and changed its name to SNDL Inc. in July 2022. SNDL Inc. was incorporated in 2006 and is headquartered in Calgary, Canada.

About InMode

(Get Free Report)

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.

Receive News & Ratings for SNDL Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SNDL and related companies with MarketBeat.com's FREE daily email newsletter.